Related Experiment Video
Updated: Jul 11, 2026
07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine-6-glucuronide (M6G) for postoperative pain relief
Albert Dahan1, Eveline van Dorp, Terry Smith
1Department of Anesthesiology, Leiden University Medical Center, P5-Q, P.O. Box 9600, 2300 RC Leiden, The Netherlands. a.dahan@lumc.nl
European Journal of Pain (London, England)
|September 18, 2007
Summary
Morphine-6-glucuronide (M6G) offers effective pain relief comparable to morphine. Studies suggest M6G may reduce opioid side effects like nausea and respiratory depression, indicating potential for improved postoperative pain management.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Trials
Background:
- Morphine-6-glucuronide (M6G) is an active metabolite of morphine.
- M6G acts on the mu-opioid receptor.
- Opioid analgesics are commonly used for postoperative pain but are associated with side effects.
Purpose of the Study:
- To review the pharmacological properties of M6G.
- To evaluate the clinical evidence for M6G's efficacy and safety in pain relief.
- To discuss the potential future role of M6G in managing postoperative pain.
Main Methods:
- Review of experimental human studies.
- Analysis of randomized clinical trials.
- Pharmacological and clinical data assessment.
Main Results:
- M6G provides pain relief comparable to morphine.
- Evidence suggests M6G may reduce postoperative nausea and vomiting (PONV).
- M6G appears to cause less respiratory depression than morphine.
Conclusions:
- M6G demonstrates significant efficacy and a potentially favorable safety profile for postoperative pain.
- M6G may offer an alternative opioid analgesic with reduced side effect burden.
- Further research and clinical application of M6G in postoperative pain management are warranted.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...